Autoimmune Neurology
Nuvig Therapeutics Inc. is engaged in clinical research for chronic inflammatory demyelinating polyneuropathy, with interest in immune-mediated disorders that affect peripheral nerve function and motor-sensory control.
- CIDP
- Peripheral neuropathy
- Immune-mediated demyelination
The sponsor’s work in this area centers on therapeutic development for neuromuscular disability associated with inflammatory nerve injury.
Hematologic Immunology
The company also funds clinical research in immune thrombocytopenia, focusing on immune-driven platelet disorders and related bleeding risk.
- ITP
- Thrombocytopenia
- Autoimmune hematologic disease
This area reflects interest in immune regulation within disorders of platelet destruction and impaired hemostasis.
Inflammatory and Immune Modulation
Across its clinical program, the sponsor is focused on immune system modulation in conditions where aberrant inflammatory activity contributes to tissue dysfunction.
- Inflammation
- Autoimmunity
- Immunologic therapeutics
Its research activity highlights therapeutic interest in disease areas driven by dysregulated immune responses.
